Collateral Ligament Stabilizer System Market Worth $2.36 Billion By 2025

November 2017 | Report Format: Electronic (PDF)

Collateral Ligament Stabilizer System Market Growth & Trends

The global collateral ligament stabilizer system market size is expected to reach USD 2.36 billion by 2025, at a CAGR of 6.7% according to a new report by Grand View Research, Inc. An increase in the number of sports injuries and road accidents is expected to boost the adoption of Collateral Ligament Stabilizer System (CLSS). According to Stanford Children’s Health, around 3.5 million children aged 14 years and below are affected by some form of sport-related injury every year. This shows the potential demand for CLSS in the coming years.

Nearly one-third of all injuries affecting children arise due to sport-related activities. Sports Medicine Australia also estimated that 1 in 17 Australians suffer from sports trauma each year. According to the Zurich American Insurance Company, 62% of the injuries related to organized sports occur during practices. Thus, increasing sports-related injuries has resulted in the high demand for collateral ligament stabilizer systems.

According to WHO, every year nearly 1.25 million people die due to road accidents and about 20 to 50 million are injured. Thus, the rise in the number of road accidents is anticipated to heighten the adoption of CLSS.

Furthermore, the increasing geriatric population across the globe is another major factor propelling the growth of the CLSS market. According to a report published by the U.S. Census Bureau, Japan has the highest percentage of the aging population in the world. In 2015, about 26.6% of the population in Japan was aged 65 years and over, which accounted for nearly 33.7 million people.


 Request a free sample copy or view report summary: Collateral Ligament Stabilizer System Market Report


Collateral Ligament Stabilizer System Market Report Highlights

  • The medial collateral ligament segment held the dominant share owing to the increase in the number of medial collateral ligament trauma resulting from sports or road accidents

  • The grade 2 injury segment is anticipated to grow at a lucrative CAGR due to the increase in the number of grade 2 injuries and recommendations by medical practitioners to use collateral ligament stabilizer systems in such cases

  • On the basis of end use, orthopedic clinics held the largest share of the collateral ligament stabilizer system market owing to the increase in the establishment of specialty clinics and the growing preference of patients for such clinics

  • Asia Pacific is anticipated to grow at a lucrative CAGR owing to the presence of high untapped opportunities, rising prevalence of chronic conditions such as osteoarthritis, and rise in the number of accident & trauma cases

Collateral Ligament Stabilizer System Market Segmentation

Grand View Research has segmented the Collateral Ligament Stabilizer System (CLSS) market on the basis of the ligament, injury, end use, and region:

Collateral Ligament Stabilizer System Ligament Outlook (Revenue, USD Million, 2014 - 2025)

  • Medial Collateral Ligament (MCL)

  • Lateral Collateral Ligament (LCL)

Collateral Ligament Stabilizer System Injury Type Outlook (Revenue, USD Million, 2014 - 2025)

  • Grade 1

  • Grade 2

  • Grade 3

Collateral Ligament Stabilizer System End-use Outlook (Revenue, USD Million, 2014 - 2025)

  • Hospitals

  • Orthopedic Clinics

  • Others

Collateral Ligament Stabilizer System Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America

    • The U.S.

    • Canada

  • Europe

    • The U.K.

    • Germany

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • MEA

    • South Africa

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.